$3.51
-0.03 (-0.85%)
Arena Pharmaceuticals, Inc. (ARNA)
CAPS Rating:
A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

RSS Headlines
Fool UK